Decentralized and adaptive trial designs move from pilot to default in biotech development plans
Dr. Dereck Mush, MD, MBA
TriNetX
Global health research network optimizing clinical trial design and site selection.
What they do
TriNetX operates a global health research network that provides real-time access to clinical data. Life sciences companies utilize the platform to analyze patient cohorts, evaluate clinical trial feasibility, and select optimal investigational sites to speed up trial deployment.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Trial administration
- Product type
- Platform software
- Stage
- Growth
- Headquarters
- Cambridge, United States
- Region
- North America
- Founded
- 2013
- Total funding
- $102M raised
Notable investors: The Carlyle Group, Deerfield Management.
Also in Clinical Trials
Related on The Signal
Dr. Dereck Mush, MD, MBA
Oracle and AstraZeneca: Bringing Clinical Trials Closer to Care
Dr. Dereck Mush, MD, MBA
Decentralized Clinical Trials Promised Faster Recruitment. The Evidence on Actual Performance Is In.
Dr. Dereck Mush, MD, MBA
Unlocking Orphan Neuromuscular Indications: Why IntraBio's Aqneursa Approval Signals a Regulatory Re-evaluation of Small-Cohort Crossover Trials
Dr. Dereck Mush, MD, MBA